No Picture
News

Rebus Biosystems Welcomes Danilo Tait as VP Commercial Operations, EMEA

SANTA CLARA, Calif.: SANTA CLARA, Calif., Oct. 5, 2021 /PRNewswire/ — Rebus Biosystems Inc, ("Rebus Bio", "Rebus"), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced Danilo Tait as the newest member of its leadership team. Tait, who holds a PhD in… Click here to view original post… […]

No Picture
News

New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies

CARLSBAD, Calif.: CARLSBAD, Calif., Oct. 5, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the launch of Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, a GMP-manufactured cell culture medium that supports large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells. This… Click here to view original post… […]

No Picture
Uncategorized

Associate Product Manager, Genomics Sample Preparation – Thermo Fisher Scientific – San Diego, CA

The Associate Product Manager will provide leadership and execution for products in our genomics Sample Preparation business, with a focus on lifecycle product…From Thermo Fisher Scientific – Tue, 05 Oct 2021 06:23:15 GMT – View […]

No Picture
Uncategorized

Clinical Scientist/Senior Clinical Scientist, Oncolytic Immunotherapy, Immuno-Oncology – Calidi Biotherapeutics – La Jolla, CA

Candidates with a minimum of 5 years of experience in a biotechnology company; Immuno-Oncology field is preferred.From Calidi Biotherapeutics – Tue, 05 Oct 2021 03:35:19 GMT – View all La Jolla, CA jobsClick here to […]

No Picture
Uncategorized

Research Associate, Cell Culture R&D – #1358 – Tanvex BioPharma USA,Inc – San Diego, CA

Responsible for executing experiments related to formulation development from formulation definition to stability program design and execution to support…From Tanvex BioPharma USA,Inc – Tue, 05 Oct 2021 00:05:47 GMT – View all San Diego, CA […]

No Picture
Uncategorized

Buyer I (Procurement Services) – Salk Institute for Biological Studies – San Diego, CA

Experience in a science, biotechnology, academic, research or non-profit industries. Procures laboratory and administrative supplies and services within the…From Salk Institute for Biological Studies – Tue, 05 Oct 2021 00:00:07 GMT – View all San […]

No Picture
News

ContraFect’s New Phase 2 Exebacase Data Presented at IDWeekTM Demonstrates Rapid Symptom Resolution Among Patients with Staphylococcus aureus Bacteremia

YONKERS, New York, Oct. 04, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, announces… Click here to view original post… […]

No Picture
News

Progenity Announces $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules

SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive agreement with several institutional investors for the purchase and sale, in a registered direct offering priced at-the-market under Nasdaq rules, of 13,333,334 shares… Click here to view original post… […]

No Picture
News

Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer

SAN DIEGO: SAN DIEGO, Oct. 4, 2021 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced new clinical and preclinical research will be presented at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, taking place October 7 – 10, 2021. The… Click here to view original post… […]

No Picture
News

Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC

SHANGHAI and SAN DIEGO: SHANGHAI and SAN DIEGO, Oct. 4, 2021 /PRNewswire/ — Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization in Greater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based on the Conditionally Active… Click here to view original post… […]

No Picture
News

Sagimet to Present Data from Phase 2 FASCINATE-1 Trial of TVB-2640 in NASH at AASLD’s The Liver Meeting 2021

SAN MATEO, Calif.: SAN MATEO, Calif., Oct. 4, 2021 /PRNewswire/ — Sagimet Biosciences, a clinical-stage biotechnology company, announced today that consolidated results from its Phase 2 FASCINATE-1 trial of TVB-2640 in patients with nonalcoholic steatohepatitis (NASH) in the U.S. and China will be shared at The Liver Meeting 2021 of… Click here to view original post… […]

No Picture
News

Heron Therapeutics Announces Filing of a Supplemental New Drug Application for Significant Expansion of ZYNRELEF® Indication Statement Based on Successful Outcome of FDA Type C Meeting

SAN DIEGO: SAN DIEGO, Oct. 4, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced submission of a supplemental New Drug Application (NDA) for… Click here to view original post… […]

No Picture
News

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 01, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq:?CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious diseases, today announced that the Compensation Committee of its Board of Directors granted non-qualified stock option awards and restricted stock… Click here to view original post… […]

No Picture
News

AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in Generalized Pustular Psoriasis

SAN DIEGO, Oct. 02, 2021 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced that week 16 data from the GPP GALLOP Phase 2 trial of imsidolimab, its investigational… Click here to view original post… […]

No Picture
Uncategorized

Senior Regional Technical Sales Manager – Production Chemicals – Thermo Fisher Scientific – San Diego, CA

Our Senior Regional Technical Sales Manager is responsible for managing a team of Technical Sales Specialists who provide solutions of both Technical and…From Thermo Fisher Scientific – Sat, 02 Oct 2021 06:24:03 GMT – View […]